MD Magazine® Staff

The smaller, incomplete study is looking into both the efficacy and safety of the longtime therapy for patients with RA.

Repository corticotropin injection’s nearly six-decade history as a therapy has been tumultuous, but has most recently resulted in its use as an auto-immune drug.

Speaking ambitiously, determining the right tests and initial therapies for patients with rheumatoid arthritis could become optimized.

Researchers have found several urinary biomarkers that may be used to predict rheumatoid arthritis activity and prognosis.

Gout is associated with a significantly increased risk of cancer, particularly prostate cancer in men, a recent study finds.

Horizon Pharma announced last Tuesday that the FDA had accepted its new drug application for Lodotra, a delayed-release formulation of low-dose prednisone, for treatment of rheumatoid arthritis in adults.

Tumor necrosis factor-α antagonists used to treat autoimmune diseases such as rheumatoid arthritis may pose less risk of serious infection than previously thought, a new study suggests.

Women under 50 with rheumatoid arthritis have an increased risk of breaking bones compared with women who do not have the condition, a new study finds.

African Americans are more likely to have multiple, large-joint osteoarthritis (OA) and to have knee OA, but less likely to have hand OA, a new study finds.

The medical marijuana debate isn't going away any time soon. See what our experts have to say about the latest information and tell us what you think.

Antares Pharma, Inc. has announced positive results of an auto-injector that delivers a rapid subcutaneous injection of methotrexate.

Isabelle Jeanson, a Doctors Without Borders/Médecins Sans Frontières emergency communications officer, has been with the MSF teams in Port-au-Prince since January 15. Here she describes the situation as of January 17.